Institutional Ownership
Abvc Biopharma Inc
CUSIP 00091F304COM NEWABVCQ1 2026
Institutional Holders
11
13F filers
Shares Held
528.6K
Aggregate institutional
Institutional Value
$512.8K
Q1 2026
Net New Holders
-2
4 new · 6 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions4
Increased2
Decreased2
Sold out6
Institutional Holders
11 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 221.2K | $214.6K | +18.8K | Added |
| 2 | Renaissance Technologies LLC | 95.1K | $92.3K | −19.2K | Reduced |
| 3 | State Street Corp | 72.8K | $70.6K | 0 | Held |
| 4 | Blackrock, Inc. | 56.4K | $54.8K | 0 | Held |
| 5 | Northern Trust Corp | 32.1K | $31.1K | 0 | Held |
| 6 | Two Sigma Securities, LLC | 21.0K | $20.4K | +21.0K | New |
| 7 | Dimensional Fund Advisors LP | 12.2K | $11.9K | +12.2K | New |
| 8 | Squarepoint Ops LLC | 10.5K | $10.2K | +10.5K | New |
| 9 | Tower Research Capital LLC (Trc) | 5.4K | $5.3K | +2.2K | Added |
| 10 | Ubs Group AG | 1.8K | $1.7K | −817 | Reduced |
1 more institutional holders on Premium
See every fund holding Abvc Biopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders